Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone

Background: The evidence for the efficacy of glucocorticoids combined with tocilizumab (TCZ) in COVID-19 comes from observational studies or subgroup analysis. Our aim was to compare outcomes between hospitalized COVID-19 patients who received high-dose corticosteroid pulse therapy and TCZ and those...

Descripción completa

Detalles Bibliográficos
Autores principales: Belhassen-García, Moncef, Sánchez-Puente, Antonio, Dorado-Díaz, Pedro-Ignacio, López-Bernús, Amparo, Sampedro-Gómez, Jesús, Azibeiro-Melchor, Raúl, Marcano-Millán, Edgard, Rodríguez-Alonso, Beatriz, Sánchez-Barrado, María-Elisa, Hernández-García, Ignacio, Madruga, Ignacio, Hernández-Pérez, Guillermo, Carbonell, Cristina, García-Aparicio, Judit, Burgos, Laura, López-Sánchez, Eugenia, Reina, Carlos, Ramón, Ana-María, Cestero-Ramírez, Laura, Boumhir, Fátima, Encinas-Sánchez, Daniel, Sánchez-Ledesma, María, Herráez, Jacinto, Araoz, Patricia, Sánchez-Crespo, María-José, Rodríguez-Rodríguez, Sandra, Rodríguez-Gude, Ana-Elisa, Sánchez-Hernández, Miguel-Vicente, Borrás, Rafael, Sagredo-Meneses, Víctor, Sánchez, Pedro-Luis, Marcos, Miguel, Martín-Oterino, José-Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746130/
https://www.ncbi.nlm.nih.gov/pubmed/35011938
http://dx.doi.org/10.3390/jcm11010198

Ejemplares similares

Ejemplares similares